Compare SCNI & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCNI | CHNR |
|---|---|---|
| Founded | 2003 | N/A |
| Country | Israel | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6M | 4.7M |
| IPO Year | N/A | 1995 |
| Metric | SCNI | CHNR |
|---|---|---|
| Price | $0.94 | $3.94 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 41.7K | 19.1K |
| Earning Date | 11-24-2025 | 12-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | ★ $1,147,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $4.55 | ★ N/A |
| Revenue Growth | ★ 303.87 | N/A |
| 52 Week Low | $0.86 | $3.16 |
| 52 Week High | $6.18 | $8.20 |
| Indicator | SCNI | CHNR |
|---|---|---|
| Relative Strength Index (RSI) | 38.13 | 45.79 |
| Support Level | $1.14 | $3.75 |
| Resistance Level | $1.26 | $4.31 |
| Average True Range (ATR) | 0.10 | 0.27 |
| MACD | 0.02 | 0.10 |
| Stochastic Oscillator | 13.13 | 43.35 |
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.
China Natural Resources Inc is engaged in exploration for lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and exploration of attractive opportunities in other sectors. The company has a single operating segment: exploration and mining.